Cutera, Inc.

Cutera, Inc. provides aesthetic and dermatology solutions worldwide. The company develops energy-based product platforms for medical practitioners. Its products include AviClear for acne treatment, Secret PRO for skin resurfacing, truFlex for muscle stimulation, and more. Cutera also offers truSculpt for body contouring, Secret RF for skin tightening, and Enlighten SR/III for tattoo removal and lesion treatment. Additionally, the company provides Excel HR for hair removal, xeo for multi-application treatments, and Secret DUO for various aesthetic concerns. Products are sold through direct sales, services, and distributors. The company was incorporated in 1998 and is headquartered in California.

Overview

Sector

Medical Devices

Target Price

0.0 USD

Current Price

0.0 USD

Potential

-100%

Strengths

No significant strengths identified based on the analyzed metrics.

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Price to book ratio (100.00) is significantly higher than the sector mean (13.90).
Analysts expect revenues to decline in the coming year.
The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
The company have lower returns than the sector in which it operates. ROIC (0.00%) is significantly lower than the sector mean (2.97%).
EV/EBIT (100.00) is significantly higher than the sector mean.
EBITDA Margin (0.00%) appears relatively low.

Key Financial Data

Indicator	Value
PER	100.0
EV/EBITDA	100.0
Price/Free Cash Flow'	100.0
ROIC	-%
Net Debt/EBITDA	100.0